相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis
Rui Li et al.
JOURNAL OF IMMUNOLOGY (2017)
Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies
Sreeja Gopal et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies
Sreeja Gopal et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments
Haiyan Peng et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells
Megan M. Blewett et al.
SCIENCE SIGNALING (2016)
Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells
Megan M. Blewett et al.
SCIENCE SIGNALING (2016)
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis
Mackenzie A. Michell-Robinson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS
Benedetta Parodi et al.
ACTA NEUROPATHOLOGICA (2015)
A Single miRNA-mRNA Interaction Affects the Immune Response in a Context- and Cell-Type-Specific Manner
Li-Fan Lu et al.
IMMUNITY (2015)
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway
Qin Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
A Comparative Analysis of Multiple Sclerosis-Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate
Djordje Miljkovic et al.
JOURNAL OF IMMUNOLOGY (2015)
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Geoffrey O. Gillard et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Control of autoimmune CNS inflammation by astrocytes
Veit Rothhammer et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Fumarate induces redox-dependent senescence by modifying glutathione metabolism
Liang Zheng et al.
NATURE COMMUNICATIONS (2015)
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes
He Huang et al.
REDOX BIOLOGY (2015)
IgLON Cell Adhesion Molecules Are Shed from the Cell Surface of Cortical Neurons to Promote Neuronal Growth
Ricardo Sanz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Direct and Indirect Effects of Immune and Central Nervous System-Resident Cells on Human Oligodendrocyte Progenitor Cell Differentiation
Craig S. Moore et al.
JOURNAL OF IMMUNOLOGY (2015)
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro
Melanie S. Brennan et al.
PLOS ONE (2015)
Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study
Douglas L. Arnold et al.
JOURNAL OF NEUROLOGY (2014)
miR-155 as a Multiple Sclerosis-Relevant Regulator of Myeloid Cell Polarization
Craig S. Moore et al.
ANNALS OF NEUROLOGY (2013)
miR-223: infection, inflammation and cancer
M. Haneklaus et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Reactive Oxygen Species from Human Astrocytes Induced Functional Impairment and Oxidative Damage
Wen S. Sheng et al.
NEUROCHEMICAL RESEARCH (2013)
Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
R. Gold et al.
CLINICAL IMMUNOLOGY (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1
Shao Xia Lin et al.
ASN NEURO (2011)
Enhancing remyelination in disease-can we wrap it up?
Mark R. Kotter et al.
BRAIN (2011)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Interferon Regulatory Factor 3 Inhibits Astrocyte Inflammatory Gene Expression Through Suppression of the Proinflammatory miR-155 and miR-155
Leonid Tarassishin et al.
GLIA (2011)
Astrocytic Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) Promotes Oligodendrocyte Differentiation and Enhances CNS Myelination
Craig S. Moore et al.
JOURNAL OF NEUROSCIENCE (2011)
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
Henrik Wilms et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
Darius Moharregh-Khiabani et al.
PLOS ONE (2010)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Andreas Junker et al.
BRAIN (2009)
Expression and functional significance of SOCS-1 and SOCS-3 in Astrocytes
Hongwei Qin et al.
JOURNAL OF IMMUNOLOGY (2008)
Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1
Joachim C. U. Lehmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration
S. Schilling et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Multiple sclerosis:: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
TL Sorensen et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)